Ginkgo Bioworks
DNA
166 hedge funds and large institutions have $375M invested in Ginkgo Bioworks in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 35 closing their positions.
129% more call options, than puts
Call options by funds: $22.1M | Put options by funds: $9.64M
104% more capital invested
Capital invested by funds: $184M → $375M (+$191M)
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
35% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 34
0.16% more ownership
Funds ownership: 71.77% → 71.93% (+0.16%)
0% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 35
1% less funds holding
Funds holding: 167 → 166 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$14M |
| 2 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$3.83M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.71M |
| 4 |
Goldman Sachs
New York
|
+$3.53M |
| 5 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
+$3.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$8.34M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$5.38M |
| 3 |
Two Sigma Advisers
New York
|
-$3.24M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$3.2M |
| 5 |
PP
PDT Partners
New York
|
-$2.45M |
DNA Hedge Fund Activity: Q2 2025 in Review
166 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Ginkgo Bioworks (DNA) for Q2 2025, worth a combined $375M — up 104% from $184M a quarter earlier.
Fund positioning in DNA was balanced in Q2 2025: 35 funds opened new positions, 35 closed out, 46 added to existing stakes and 34 trimmed.
The largest buyer was BlackRock, adding an estimated $14M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $8.34M sold.
- 166 institutional investors held Ginkgo Bioworks (DNA) as of Q2 2025, down from 167 in Q1 2025.
- Funds reported $375M of Ginkgo Bioworks stock for Q2 2025, up 104% quarter-over-quarter.
- 35 funds opened new Ginkgo Bioworks positions in Q2 2025 and 35 closed out, a net change of 0 holders.
- The largest Ginkgo Bioworks buyer in Q2 2025 was BlackRock, an estimated $14M added.
- The largest Ginkgo Bioworks seller in Q2 2025 was EcoR1 Capital, an estimated $8.34M sold.
Based on aggregated 13F filings for Q2 2025.